A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding

Molecular and Cellular Biology

Volumn 16, Issue 10, 1996, Pages 5846-5856

  Sandmöller, Andrea ^a   Meents, Heiko ^a   Arnold, Hans Henning ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; GENE PRODUCT; HELIX LOOP HELIX PROTEIN; MUSCLE ENZYME; MUTANT PROTEIN; MYOD PROTEIN; MYOGENIN; ONCOPROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FIBROBLAST; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; ONCOGENE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; SKELETAL MUSCLE; TRANSACTIVATION;

ADENOVIRIDAE; ANIMALIA;

EID: 0029791556     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.10.5846     Document Type: Article

References (74)

1. Abraham, S. E., S. Lobo, P. Yaciuk, H.-G. H. Wang, and E. Moran. 1993. p300, and p300-associated proteins, are components of the TATA-binding protein (TBP) complexes. Oncogene 8:1639-1647.
2. Arany, Z., D. Newsome, E. Oldread, D. M. Livingston, and K. Eckner. 1995. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature (London) 374:81-84.
3. Arnold, H. H., and T. Braun. 1993. The developmental control genes in myogenesis of vertebrates, p. 111-158. In P. M. Wassarman (ed.), Advances in developmental biology, vol. 2. JAI Press, Greenwich, Conn.
4. Bayley, S. T., and J. S. Mymryk. 1994. Adenovirus E1A proteins and transformation. Int. J. Oncol. 5:425-444.
5. Bober, E., G. E. Lyons, T. Braun, G., Cossu, M. Buckingham, and H. H. Arnold. 1991. The muscle regulatory gene, Myf-6, has a biphasic pattern of expression during early mouse development. J. Cell Biol. 113:1255-1265.
6. Bondesson, M., M. Mannervik, G. Akusjarvi, and C. Svensson. 1994. An adenovirus E1A transcriptional repressor domain functions as an activator when tethered to a promoter. Nucleic Acids Res. 22:3053-3060.
7. Boulukos, K. E., and E. B. Ziff. 1993. Adenovirus 5 E1A proteins disrupt the neuronal phenotype and growth factor responsiveness of PC12 cells by a conserved region 1-dependent mechanism. Oncogene 8:237-248.
8. Braun, T., and H. H. Arnold. 1995. Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. EMBO J. 14:1176-1186.
9. Braun, T., E. Bober, and H. H. Arnold. 1992. Inhibition of muscle differentiation by the adenovirus E1A protein: repression of the transcriptional activating function of the HLH protein Myf-5. Genes Dev. 6:888-902.
10. Braun, T., E. Bober, D. G. Buschhausen, S. Kohtz, K. H. Grzeschik, and H. H. Arnold. 1989. Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products. EMBO J. 8:3617-3625.
11. Braun, T., E. Bober, W. Winter, N. Rosenthal, and H. H. Arnold. 1990. Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. EMBO J. 9:821-831.
12. Braun, T., G. Buschhausen-Denker, E. Bober, E. Tannich, and H. H. Arnold. 1989. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J. 8:3617-3625.
13. Braun, T., M. A. Rudnicki, H. H. Arnold, and R. Jaenisch. 1992. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 71:369-382.
14. Brennan, T. J., T. Chakraborty, and E. N. Olson. 1991. Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis. Proc. Natl. Acad. Sci. USA 88:5675-5679.
15. Buchberger, A., K. Ragge, and H. H. Arnold. 1994. The myogenin gene is activated during myocyte differentiation by a pre-existing, not newly synthesized transcription factor MEF2. J. Biol. Chem. 269:17289-17296.
16. Caruso, M., F. Martelli, A. Giordano, and A. Felsani. 1993. Regulation of MyoD transcription and protein function by the transforming domains of the adenovirus oncoprotein. Oncogene 8:888-902.
17. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
18. Davis, R. L., P. F. Cheng, A. B. Lassar, and H. Weintraub. 1990. The MyoD DNA-binding domain contains a recognition code for muscle-specific gene activation. Cell 60:733-746.
19. Davis, R. L., H. Weintraub, and A. B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987-1000.
20. Dorsman, J. C., B. M. Hagemeyer, J. Veenstra, P. Elfferich, N. Nabben, A. Zantema, and A. J. van der Eb. 1995. The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains. J. Virol. 69:2962-2967.
21. Eckner, R., M. E. Ewen, D. Newsome, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869-884.
22. Edmondson, D. G., and E. N. Olson. 1989. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev. 3:628-640.
23. Emerson, C. P. 1993. Skeletal myogenesis: genetics and embryology to the fore. Curr. Opin. Genet. Dev. 3:265-275.
24. Endo, T., and B. Nadal-Ginard. 1986. Transcriptional and post-transcriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiation phenotype. Mol. Cell. Biol. 6:1412-1421.
25. Enkemann, S. A., S. F. Konieczny, and E. J. Taparowsky. 1990. Adenovirus 5 E1a represses muscle-specific enhancers and inhibits expression of the myogenic regulatory factor genes, MyoD1 and myogenin. Cell Growth Differ. 1:628-640.
26. Gorman, C. 1985. High efficiency gene transfer into mammalian cells, p. 143-190. In D. M. Glover (ed.), DNA cloning - a practical approach, vol. 2. IRL Press, Oxford.
27. Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-323.
28. Hasty, P., A. Bradley, J. H. Morris, D. G. Edmondson, J. Venuti, E. N. Olson, and W. H. Klein. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature (London) 364:501-506.
29. Hinterberger, T. J., D. A. Sassoon, S. J. Rhodes, and S. F. Konieczny. 1991. Expression of the muscle regulatory factor MRF4 during somite and skeletal myofiber development. Dev. Biol. 147:144-156.
30. Hollenberg, S. M., P. F. Cheng, and H. Weintraub. 1993. Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination. Proc. Natl. Acad. Sci. USA 90:8028-8032.
31. Kirshenbaum, L. A., and M. D. Schneider. 1995. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket- and p300-binding domains. J. Cell Biol. 270: 7791-7794.
32. Konigsberg, I. R., N. McElvain, M. Tootle, and H. Herrmann. 1960. The dissociability of deoxyribonucleic acid synthesis from the development of multinuclearity of muscle cells in culture. J. Biophys. Biochem. Cytol. 8:333-343.
33. Lassar, A. B., J. N. Buskin, D. Lockshon, R. L. Davis, S. Apone, S. D. Hauschka, and H. Weintraub. 1989. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 58:823-831.
34. Lassar, A. B., R. L. Davis, W. E. Wright, T. Kadesch, C. Murre, A. Voronova, D. Baltimore, and H. Weintraub. 1991. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66:305-315.
35. Lassar, A. B., S. X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788-794.
36. Lundblad, J. R., R. P. S. Kwok, M. E. Laurance, M. L. Harter, and K. H. Goodman. 1995. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature (London) 374: 85-88.
37. Miner, J. H., and B. Wold. 1990. Herculin, a fourth member of the MyoD family of myogenic regulatory genes. Proc. Natl. Acad. Sci. USA 87:1089-1093.
38. Montarras, D., J. Chelly, E. Bober, H. H. Arnold, M.-O. Ott., F. Gros, and C. Pinset. 1991. Developmental patterns in the expression of Myf-5, MyoD, myogenin, and MRF4 during myogenesis. New Biol. 3:592-600.
39. Moran, E. 1993. Interaction of adenoviral proteins with pRB and p53. FASEB J. 7:880-885.
40. Müller, R. Personal communication.
41. Mymryk, J. S., R. W. H. Lee, and S. T. Bayley. 1992. Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300-kilodalton cellular protein. Mol. Biol. Cell 3:1107-1115.
42. Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, I. Nonaka, and Y. Nabeshima. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature (London) 364:532-535.
43. Offringa, R., S. Gebel, H. van Dam, M. Timmers, A. Smits, R. Zwart, B. Stein, J. L. Bos, A. van der Eb, and P. Herrlich. 1990. A novel function of the transforming domain of E1a: repression of AP-1 activity. Cell 62:527-538.
44. Olson, E. N., and W. H. Klein. 1994. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1-8.
45. Ott, M., E. Bober, G. Lyons, H. H. Arnold, and M. Buckingham. 1991. Early expression of the myogenic regulatory gene, myf-5, in precursor cells of skeletal muscle in the mouse embryo. Development 111:1097-1107.
46. Patapoutian, A., J. K. Yoon, J. H. Miner, S. Wang, K. Stark, and H. Wold. 1995. Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome. Development 121:3347-3358.
47. Ptashne, M. 1988. How eukaryotic transcriptional activators work. Nature (London) 335:683-689.
48. Rhodes, S. J., and S. F. Konieczny. 1989. Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. 3:2050-2061.
49. Rosenthal, N., E. B. Berglund, B. M. Wentworth, M. Donoghue, B. Winter, E. Bober, T. Braun, and H. H. Arnold. 1990. A highly conserved enhancer downstream of the human MLC1/3 locus is a target for multiple myogenic determination factors. Nucleic Acids Res. 18:6239-6245.
50. Rudnicki, M. A., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation of myoD in mice leads to up-regulation of the myogenic HLH gene myf-5 and results in apparently normal muscle development. Cell 71:383-390.
51. Rudnieki, M. A., P. N. J. Schnegelsberg, R. H. Stead, T. Braun, H. H. Arnold, and R. Jaenisch. 1993. MyoD or Myf-5 is required for the formation of skeletal muscles. Cell 75:1351-1359.
52. Salminen, A., T. Braun, S. Jürs, B. Winter, and H. H. Arnold. 1991. Transcription of the muscle regulatory gene MYF4 is regulated by serum components, peptide growth factors, and signaling pathways involving G proteins. J. Cell Biol. 115:905-917.
53. Sassoon, D., G. Lyons, W. E. Wright, V. Lin, A. Lassar, H. Weintraub, and M. Buckingham. 1989. Expression of two myogenic regulatory factors, myogenin and MyoD1, during mouse embryogenesis. Nature (London) 342:3113-307.
54. Schneider, J. W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard. 1994. Reversal of terminal differentiation mediated by p107 in pRB-/- muscle cells. Science 264:1467-1471.
55. Sogawa, K., H. Handa, A. Fujisawa-Sehara, T. Hiromasa, M. Yamane, and Y. Fujii-Kuriyama. 1989. Repression of cyotochrome p-450c gene expression by cotransfection with adenovirus E1A DNA. Eur. J. Biochem. 181:539-544.
56. Song, C. Z., P. M. Loewenstein, K. Toth, and M. Green. 1995. Transcription factor TFIID is a direct functional target of the adenovirus E1A transcription repression domain. Proc. Natl. Acad. Sci. USA 92:10330-10333.
57. Song, C. Z., C. J. Tierney, P. M. Loewenstein, R. Pusztai, J. S. Symington, Q. Tang, K. Toth, A. Nishikawa, S. T. Bayley, and M. Green. 1995. Transcriptional repression by human adenovirus E1A N terminus/conserved domain 1 polypeptides in vivo and in vitro in the absence of protein synthesis. J. Biol. Chem. 270:23263-23267.
58. Spitkovsky, D., P. Steiner, J. Lukas, E. Lees, M. Pagano, A. Schulze, S. Joswig, D. Picard, M. Tommasino, and M. Eilers. 1994. Modulation of cyclin gene expression by adenovirus E1A in a cell line with E1A-dependent conditional proliferation. J. Virol. 68:2206-2214.
59. Stein, R. W., and E. B. Ziff. 1987. Repression of insulin gene expression by adenovirus type 5 E1a proteins. Mol. Cell. Biol. 7:1164-1170.
60. Stockdale, F. E., and H. Holtzer. 1961. DNA synthesis and myogenesis. Exp. Cell Res. 24:508-520.
61. Tapscott, S. J., R. L. Davis, M. J. Thayer, P. F. Cheng, H. Weintraub, and A. B. Lassar. 1988. MyoD: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242:405-411.
62. 12S and basic helix-loop-helix proteins. Mol. Cell. Biol. 13:4714-4727.
63. Velcich, A., F. G. Kern, C. Basilico, and E. B. Ziff. 1986. Adenovirus E1a proteins repress expression from polyomavirus early and late promoter. Mol. Cell. Biol. 6:4019-4025.
64. Velcich, A., and E. Ziff. 1985. Adenovirus E1a proteins repress transcription from the SV40 early promoter. Cell 40:705-716.
65. Venuti, J. M., J. H. Morris, J. L. Vivian, E. N. Olson, and W. H. Klein. 1995. Myogenin is required for late but not early aspects of myogenesis during mouse development. J. Cell Biol. 128:563-576.
66. Wang, H.-G., Y. Rikitake, M. C., Carter, P. Yaciuk, S. E. Abraham, B. Zerler, and E. Moran. 1993. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67:476-488.
67. Webster, K. A., G. E. O. Muscat, and L. Kedes. 1988. Adenovirus E1a proteins suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature (London) 332:553-557.
68. Weintraub, H. 1993. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75:1241-1244.
69. Weintraub, H., R. Davis, S. Tapscott, M. Thayer, M. Krause, R. Benezra, T. K. Blackwell, D. Turner, R. Rupp, S. Hollenberg, Y. Zhuang, and A. Lassar. 1991. The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251:761-766.
70. Weintraub, H., V. J. Dwarki, I. Verma, R. Davis, S. Hollenberg, L. Snider, A. Lassar, and S. J. Tapscott. 1991. Muscle-specific transactivation by MyoD. Genes Dev. 5:1377-1386.
71. Whyte, P., N. M. Williamson, and E. Harlow. 1989. Cellular targets for transformation by the adenovirus E1A proteins. Cell 56:67-75.
72. Winter, B., T. Braun, and H. H. Arnold. 1992. Co-operativity of functional domains in the transcription factor Myf-5. EMBO J. 11:1843-1855.
73. Wright, W. E., D. A. Sassoon, and V. K. Lin. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to myoD1. Cell 56:607-617.
74. Zhang, W., R. R. Behringer, and E. N. Olson. 1995. Inactivation of the myogenic bHLH gene MRF4 results in upregulation of myogenin and rib abnormalities. Genes Dev. 9:1388-1399.